Lucrin Temporary Supply Shortages in Aotearoa New Zealand

AbbVie has alerted the Society that our Members in Aoteroa New Zealand may experience stock shortages of LUCRIN Depot 3-month 11.25mg PDS (Pharmacode 2330156) until approximately 23rd September 2022.

The temporary shortage is due to the supply of product and is not related to the product quality. AbbVie is working to resolve this situation with the utmost urgency.

During this period, continuity of LUCRIN therapy may be maintained by using the alternative LUCRIN Depot 1-month 3.75mg PDS presentation.

Access the full statement from AbbVie.